On the management of menopause syndrome patients
| Autor: | N A Tatarova, N P Gavrilova |
|---|---|
| Jazyk: | ruština |
| Rok vydání: | 2013 |
| Předmět: | |
| Zdroj: | Гинекология, Vol 15, Iss 3, Pp 17-19 (2013) |
| Druh dokumentu: | article |
| ISSN: | 2079-5696 2079-5831 |
| Popis: | Research objective. Development of a program of follow-up for women with menopausal metabolic syndrome and cholestasis; determination of the effectiveness of the Femoston in combination with Ursofalk. Materials and methods. 71 women with climacteric syndrome, obesity and cholestasis were under observation; a comprehensive clinical and laboratory examination was carried out, measurement of modified menopausal index before treatment and after 6 months. The results. Positive changes in neurocirculation symptoms and lipid profile were obtained, a statistically significant reduction in transaminases and modified menopausal index, the coagulation parameters remained virtually unchanged. Conclusion. The Femoston and Ursofalk positively influence the climacteric syndrome; normalize lipid profile, having positive influence on the hepatobiliary system. It is appropriate to prescribe this medicine to the patients with menopausal metabolic syndrome and cholestasis. |
| Databáze: | Directory of Open Access Journals |
| Externí odkaz: |
|